Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR1 | Q92633 | 5/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | CXCR5 | P32302 | 7/20 | 0.38 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.36 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18874036 | 0.89 | LPAR1 (0.56) | LPAR1MAPTKMT2AALDH1A1CXCR5 | |
| SCHEMBL18873882 | 0.87 | LPAR1 (0.56) | LPAR1CXCR5SIRT2C5AR1MCHR1 | |
| SCHEMBL18874189 | 0.87 | LPAR1 (0.58) | LPAR1KMT2ACXCR5SIRT2MEN1 | |
| SCHEMBL18873934 | 0.87 | LPAR1 (0.54) | LPAR1MAPTKMT2ACXCR5SIRT2 | |
| SCHEMBL18874205 | 0.86 | LPAR1 (0.56) | LPAR1SIRT2C5AR1 | |
| SCHEMBL18874199 | 0.86 | LPAR1 (0.57) | LPAR1ALDH1A1CXCR5SIRT2C5AR1 | |
| SCHEMBL18873905 | 0.86 | LPAR1 (0.57) | LPAR1CXCR5SIRT2C5AR1 | |
| SCHEMBL18874159 | 0.86 | LPAR1 (0.57) | LPAR1CXCR5SIRT2C5AR1 | |
| SCHEMBL1561173 | 0.86 | LPAR1 (0.74) | LPAR1CXCR5 | |
| SCHEMBL18873898 | 0.85 | LPAR1 (0.56) | LPAR1KMT2ACXCR5SIRT2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2303270-B1 | ACYLAMINO-SUBSTITUTED FUSED CYCLOPENTANECARBOXYLIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | SANOFI SA (FR) | 2017-05-17 | — | — | EP | disclosed |